LTLu Tan

Lu Tan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lu Tan has a total of 70 co-authors. Here are the top co-authors by number of shared publications:

  • Johannes Kirchmair

    University of Vienna

    3 shared publications
  • José Batista

    Department of Life Science Informatics, B-IT, LIMES, Program Unit Medicinal Chemistry and Chemical Biology, Rheinische Friedrich-Wilhelms-Universität Bonn, Dahlmannstr. 2, D-53113 Bonn, Germany

    3 shared publications
  • Jürgen Bajorath

    Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Dahlmannstrasse 2, D-53113 Bonn, Germany and In-Silico Center, JADO Technologies GmbH, Tatzberg 47-51, D-01307 Dresden, Germany

    3 shared publications
  • Jürgen Bajorath

    address:‐bonn.de

    3 shared publications
  • David A. Lomas

    Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, UK

    2 shared publications
  • A Ordonez

    University of Cambridge, Cambridge, UK

    1 shared publication

Latest Publications

  • Software for Metabolism Prediction

    by Lu Tan, Johannes Kirchmair


  • Open Access

    S64 Circulating polymers are found in alpha-1-antitrypsin deficiency and are associated with lung disease

    by Ja Dickens, L Tan, DL DeMeo, E Miranda, J Perez, St Rashid, J Day, A Ordonez, Sj Marciniak, I Haq, et al.

    Introduction and Objectives The severe Z deficiency allele of alpha-1-antitrypsin (Glu342Lys) results in the formation of polymers that are retained within hepatocytes, leading to hepatitis, cirrhosis and hepatocellular carcinoma. The concomitant lack of circulating protein predisposes to early onset emphysema. Polymers are also found in the lung, skin and kidney and are known to be proinflammatory, but it is unknown whether those polymers are produced locally or are deposited from a circulating source. We wished to establish whether polymers are present in the plasma of individuals with alpha-1-antitrypsin deficiency, from where they originate and whether they are associated with any clinical phenotype. Methods We used a novel anti-alpha-1-antitrypsin polymer monoclonal antibody (2C1) in an ELISA assay to evaluate whether polymers are present in a cohort of 513 individuals with ZZ alpha-1-antitrypsin deficiency. Serial samples from an individual with ZZ alpha-1-antitrypsin deficiency undergoing liver transplantation were used to investigate the source of circulating polymers. We then used a 2nd cohort of 293 individuals with mixed alpha-1-antitrypsin phenotypes to determine whether circulating polymers could be used as a screening test for the presence of a polymerogenic allele. Disease associations were sought using clinical data from the ZZ alpha-1-antitrypsin deficient cohort. Results In the cohort of 513 individuals with PiZZ alpha-1-antitrypsin deficiency, we found 512 had quantifiable polymers present within serum, the 513th having previously had a liver transplant. Circulating polymer levels were higher in men and individuals with COPD and a there was a correlation with older age and lower lung function. The presence of circulating polymers was 100% sensitive and 89% specific in identifying 20 PiZZ alpha-1-antitrypsin homozygotes in a mix of 293 alpha-1-antitrypsin genotypes. Serial blood samples from a PiZZ individual undergoing liver transplantation showed that circulating polymers originate from the liver, clearing with a half-life of approximately 30 hours and becoming undetectable 5 days after transplantation. Conclusions We have shown that circulating polymers are present in PiZZ alpha-1-antitrypsin individuals and originate from the liver. Polymer levels are associated with COPD, suggesting they may play a role in disease pathogenesis. Z α1 antitrypsin polymers are present in the circulation and are cleared following liver transplantation. Mouse monoclonal antibodies that detect all conformers of α1-antitrypsin, or only polymeric (α1-antitrypsin (2C1), were used to quantify total (α1-antitrypsin and (α1-antitrypsin polymers respectively using sandwich ELISA. Time points marked * are below the lower limit of quantification (0.4 ug/mL).

  • Support Vector Machine (SVM) Models for Predicting Inhibitors of the 3′ Processing Step of HIV‐1 Integrase

    by Shouyi Xuan, Maolin Wang, Hang Kang, Johannes Kirchmair, Lu Tan, Aixia Yan

    Inhibition of the 3′ processing step of HIV‐1 integrase by small molecule inhibitors is one of the most promising strategies for the treatment of AIDS. Using a support vector machine (SVM) approach, we developed six classification models for predicting 3′P inhibitors. The models are based on up to 48 selected molecular descriptors and a comprehensive data set of 1253 molecules, with measured activities ranging from nanomolar to micromolar IC50 values. Model B2, the most robust SVM model, obtains a prediction accuracy, sensitivity, specificity and Matthews correlation coefficient (MCC) of 93 %, 81 %, 94 % and 0.67 on the test set, respectively. The presence of hydrogen bonding features and hydrophilicity in general were identified as key determinants of inhibitory activity. Further important properties include molecular refractivity, π atom charge, total charge, lone pair electronegativity, and effective atom polarizability. Comparative fragment‐based analysis of the active and inactive molecules corroborated these observations and revealed several characteristic structural elements of 3′P inhibitors. The models built in this study can be obtained from the authors.


  • Open Access

    Endoplasmic reticulum polymers impair luminal protein mobility and sensitize to cellular stress in alpha1-antitrypsin deficiency

    by Adriana Ordóñez, Erik L. Snapp, Lu Tan, Elena Miranda, Stefan J. Marciniak, David A. Lomas

    Point mutants of alpha1-antitrypsin (α1AT) form ordered polymers that are retained as inclusions within the endoplasmic reticulum (ER) of hepatocytes in association with neonatal hepatitis, cirrhosis, and hepatocellular carcinoma. These inclusions cause cell damage and predispose to ER stress in the absence of the classical unfolded protein response (UPR). The pathophysiology underlying this ER stress was explored by generating cell models that conditionally express wild-type (WT) α1AT, two mutants that cause polymer-mediated inclusions and liver disease (E342K [the Z allele] and H334D) and a truncated mutant (Null Hong Kong; NHK) that induces classical ER stress and is removed by ER-associated degradation. Expression of the polymeric mutants resulted in gross changes in the ER luminal environment that recapitulated the changes observed in liver sections from individuals with PI*ZZ α1AT deficiency. In contrast, expression of NHK α1AT caused electron lucent dilatation and expansion of the ER throughout the cell. Photobleaching microscopy in live cells demonstrated a decrease in the mobility of soluble luminal proteins in cells that express E342K and H334D α1AT, when compared to those that express WT and NHK α1AT (0.34 ± 0.05, 0.22 ± 0.03, 2.83 ± 0.30, and 2.84 ± 0.55 μm2/s, respectively). There was no effect on protein mobility within ER membranes, indicating that cisternal connectivity was not disrupted. Polymer expression alone was insufficient to induce the UPR, but the resulting protein overload rendered cells hypersensitive to ER stress induced by either tunicamycin or glucose depletion. Conclusion : Changes in protein diffusion provide an explanation for the cellular consequences of ER protein overload in mutants that cause inclusion body formation and α1AT deficiency.


  • Circulating Polymers Of Alpha-1 Antitrypsin In PI ZZ Subjects

    by Dawn L. DeMeo, Maria Elena Banos, Juan Perez, Lu Tan, Alan F. Barker, Ed Campbell, Edward Eden, Noel G. McElvaney, Stephen I. Rennard, Robert A. Sandhaus, et al.

  • Top Cited Papers
    Open Access

    Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms

    by Johannes Kirchmair, Mark J. Williamson, Jonathan D. Tyzack, Lu Tan, Peter J. Bond, Andreas Bender, Robert C. Glen

    Metabolism of xenobiotics remains a central challenge for the discovery and development of drugs, cosmetics, nutritional supplements, and agrochemicals. Metabolic transformations are frequently related to the incidence of toxic effects that may result from the emergence of reactive species, the systemic accumulation of metabolites, or by induction of metabolic pathways. Experimental investigation of the metabolism of small organic molecules is particularly resource demanding; hence, computational methods are of considerable interest to complement experimental approaches. This review provides a broad overview of structure- and ligand-based computational methods for the prediction of xenobiotic metabolism. Current computational approaches to address xenobiotic metabolism are discussed from three major perspectives: (i) prediction of sites of metabolism (SOMs), (ii) elucidation of potential metabolites and their chemical structures, and (iii) prediction of direct and indirect effects of xenobiotics on metabolizing enzymes, where the focus is on the cytochrome P450 (CYP) superfamily of enzymes, the cardinal xenobiotics metabolizing enzymes. For each of these domains, a variety of approaches and their applications are systematically reviewed, including expert systems, data mining approaches, quantitative structure–activity relationships (QSARs), and machine learning-based methods, pharmacophore-based algorithms, shape-focused techniques, molecular interaction fields (MIFs), reactivity-focused techniques, protein–ligand docking, molecular dynamics (MD) simulations, and combinations of methods. Predictive metabolism is a developing area, and there is still enormous potential for improvement. However, it is clear that the combination of rapidly increasing amounts of available ligand- and structure-related experimental data (in particular, quantitative data) with novel and diverse simulation and modeling approaches is accelerating the development of effective tools for prediction of in vivo metabolism, which is reflected by the diverse and comprehensive data sources and methods for metabolism prediction reviewed here. This review attempts to survey the range and scope of computational methods applied to metabolism prediction and also to compare and contrast their applicability and performance.


  • Open Access

    Computational Methodologies for Compound Database Searching that Utilize Experimental Protein–Ligand Interaction Information

    by Lu Tan, Jose Batista, Jürgen Bajorath

    Ligand- and target structure-based methods are widely used in virtual screening, but there is currently no methodology available that fully integrates these different approaches. Herein, we provide an overview of various attempts that have been made to combine ligand- and structure-based computational screening methods. We then review different types of approaches that utilize protein-ligand interaction information for database screening and filtering. Interaction-based approaches make use of a variety of methodological concepts including pharmacophore modeling and direct or indirect encoding of protein-ligand interactions in fingerprint formats. These interaction-based methods have been successfully applied to tackle different tasks related to virtual screening including postprocessing of docking poses, prioritization of binding modes, selectivity analysis, or similarity searching. Furthermore, we discuss the recently developed interacting fragment approach that indirectly incorporates 3D interaction information into 2D similarity searching and bridges between ligand- and structure-based methods.


  • Rationalization of the Performance and Target Dependence of Similarity Searching Incorporating Protein−Ligand Interaction Information

    by Lu Tan, José Batista, Jürgen Bajorath

    Interacting fragments (IFs) derived from protein-ligand complex crystal structures have previously been utilized to complement conventional two-dimensional (2D) similarity searching. In many instances, the (indirect) incorporation of three-dimensional (3D) interaction information through the use of IFs has further improved the search performance of fingerprints of unmodified ligands. However, for a number of targets, changes in the relative performance of conventional fingerprints and IF-based representations have also been observed, and reasons for these effects have thus far remained elusive. Herein, we analyze target-ligand systems that display different similarity search phenotypes. We study protein-ligand interactions and the resulting IF information at the molecular level of detail in order to better understand systematic differences in the search performance of unmodified ligands and IFs. The results show that the degree of conservation of IFs isolated from multiple crystallographic ligands is a major determinant of similarity search performance, regardless of whether IFs consist of coherent substructures or disjoint fragments. Conserved IFs focus similarity search calculations on 2D pharmacophore elements, as revealed by 3D interaction analysis. This leads to increased hit rates compared to unmodified reference ligand representations and to the recognition of smaller and less complex, yet structurally diverse hits. On the basis of these findings, one can predict for which targets the inclusion of IF information will likely result in improved 2D similarity search performance.


  • Atom-Centered Interacting Fragments and Similarity Search Applications

    by José Batista, Lu Tan, Jürgen Bajorath

    Parts of ligands in complex crystal structures that are involved in well-defined protein−ligand interactions are extracted and encoded as ensembles of atom-centered fragments, termed atom-centered interacting fragments (AIFs), which implicitly capture three-dimensional interaction information. AIF reference sets are utilized for feature count-based ranking of databases to search for molecules having similar activity. AIF calculations are reported for eight enzyme targets with multiple crystallographic inhibitor complexes and, in addition, for a complex of a G protein coupled receptor with an antagonist. The AIF approach further increases compound recall of structural key-based fingerprints. Moreover, AIF combinations are found to be specific markers of different classes of active compounds that lead to an early enrichment of inhibitors and selective antagonists in similarity search calculations.


  • Three‐Dimensional Protein–Ligand Interaction Scaling of Two‐Dimensional Fingerprints

    by Lu Tan, Martin Vogt, Jürgen Bajorath

    We introduce a computational scaling methodology that utilizes protein-ligand interaction information extracted from complex crystal structures to enrich similarity searching using structural fingerprints with compound class-specific information. Scaling factors are derived to emphasize fingerprint bit positions that result from interacting fragments of bound ligands and correspond to frequently occurring structural features. Through interaction-based scaling, this information is transferred to standard fingerprints of multiple reference compounds. In systematic search calculations, fingerprints scaled on the basis of three-dimensional information are found to produce higher recall rates of active compounds than alternative types of scaled and non-scaled fingerprints.